{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T23:21:07Z","timestamp":1761952867605,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.lungcan.2008.03.014","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T15:43:22Z","timestamp":1209570202000},"page":"141-151","source":"Crossref","is-referenced-by-count":6,"title":["What has the meta-analysis contributed to today's standard of care in the treatment of thoracic malignancies?"],"prefix":"10.1016","volume":"61","author":[{"given":"Anne-Pascale","family":"Meert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Paul","family":"Sculier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2008.03.014_bib1","doi-asserted-by":"crossref","first-page":"8S81","DOI":"10.1016\/S0761-8425(05)85777-8","article-title":"Traitements en oncologie thoracique: l\u2019apport des m\u00e9ta-analyses","volume":"22","author":"Sculier","year":"2005","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.lungcan.2008.03.014_bib2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/thx.2005.051995","article-title":"Surgery for non-small cell lung cancer: systematic review and meta-analysis of randomised controlled trials","volume":"61","author":"Wright","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.lungcan.2008.03.014_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/sj.bjc.6602414","article-title":"Survival following lobectomy vs. limited resection for stage I lung cancer: a meta-analysis","volume":"92","author":"Nakamura","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejcts.2007.03.018","article-title":"Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? A meta-analysis","volume":"32","author":"Ma","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.lungcan.2008.03.014_bib5","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/bmj.311.7010.899","article-title":"Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials","volume":"311","year":"1995","journal-title":"Br Med J"},{"key":"10.1016\/j.lungcan.2008.03.014_bib6","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2004.01.153","article-title":"Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials","volume":"22","author":"Hotta","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jtcvs.2004.04.027","article-title":"Postoperative chemotherapy for non-small cell lung cancer: a systematic review and meta-analysis","volume":"128","author":"Sedrakyan","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2008.03.014_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2005.01.002","article-title":"Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature","volume":"49","author":"Berghmans","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib9","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1200\/JCO.2005.09.017","article-title":"Meta-analysis of postoperative adjuvant chemotherapy with tegafur\u2013uracil in non-small-cell lung cancer","volume":"23","author":"Hamada","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib10","first-page":"477","article-title":"R\u00f4le de la chimioth\u00e9rapie dans le traitement des cancers bronchiques non \u00e0 petites cellules m\u00e9tastatiques","volume":"22","author":"Sculier","year":"2001","journal-title":"Rev Med Bru"},{"key":"10.1016\/j.lungcan.2008.03.014_bib11","first-page":"611","article-title":"A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer","volume":"1","author":"Burdett","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.lungcan.2006.07.019","article-title":"Role of preoperative chemotherapy for non-small-cell lung cancer: a meta-analysis","volume":"54","author":"Nakamura","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.lungcan.2004.09.010","article-title":"Postoperative radiotherapy in non small cell lung cancer: update of an individual patient data meta-analysis","volume":"47","author":"Burdett","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0140-6736(98)06341-7","article-title":"Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2008.03.014_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/1097-0142(19950815)76:4<593::AID-CNCR2820760409>3.0.CO;2-N","article-title":"Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis","volume":"76","author":"Marino","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.7326\/0003-4819-125-9-199611010-00003","article-title":"Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer. A meta-analysis","volume":"125","author":"Pritchard","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lungcan.2008.03.014_bib17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/annonc\/mdj117","article-title":"Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients","volume":"17","author":"Auperin","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0360-3016(03)01447-0","article-title":"Comparison of the efficacy and acute toxicity of weekly versus daily chemoradiotherapy for non-small-cell lung cancer: a meta-analysis","volume":"58","author":"Rakovitch","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.lungcan.2008.03.014_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0140-6736(93)91882-M","article-title":"Polychemotherapy in advanced non small cell lung cancer: a meta-analysis","volume":"342","author":"Souquet","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.lungcan.2008.03.014_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1378\/chest.106.3.861","article-title":"Chemotherapy vs. supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature","volume":"106","author":"Marino","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.lungcan.2008.03.014_bib21","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1200\/JCO.1993.11.10.1866","article-title":"Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?","volume":"11","author":"Grilli","year":"1993","journal-title":"J Clin Oncol"},{"year":"1999","series-title":"Best supportive care or chemotherapy for stage IV non small cell lung cancer. Progress and perspectives in lung cancer","author":"Sculier","key":"10.1016\/j.lungcan.2008.03.014_bib22"},{"key":"10.1016\/j.lungcan.2008.03.014_bib23","first-page":"197","article-title":"Chemotherapy of non-small cell bronchial cancers. Meta-analysis of the literature as a function of the extent of the disease","volume":"8","author":"Donnadieu","year":"1991","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.lungcan.2008.03.014_bib24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1054\/bjoc.2001.1742","article-title":"The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature","volume":"84","author":"Sculier","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2004.10.014","article-title":"Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non small cell lung cancer: a meta-analysis of survival outcomes","volume":"47","author":"Le","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib26","first-page":"281","article-title":"Docetaxel in combination with cisplatin for first-line treatment of locally advanced or metastatic non-small cell lung cancer: metaanalysis of randomized and controlled clinical trials","volume":"122","author":"Sanchez","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.lungcan.2008.03.014_bib27","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/annonc\/mdh476","article-title":"Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials","volume":"15","author":"Hotta","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib28","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2004.02.109","article-title":"Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer","volume":"22","author":"Hotta","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.lungcan.2007.03.014","article-title":"A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer","volume":"57","author":"Jiang","year":"2007","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnci\/djk196","article-title":"Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis","volume":"99","author":"Ardizzoni","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2008.03.014_bib31","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1200\/JCO.2005.03.045","article-title":"Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature","volume":"23","author":"D\u2019addario","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.lungcan.2005.11.001","article-title":"Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials","volume":"51","author":"Pujol","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/JTO.0b013e318153fa2b","article-title":"Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials","volume":"2","author":"Douillard","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0169-5002(95)00477-I","article-title":"Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis study","volume":"13","author":"Marino","year":"1995","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<116::AID-CNCR14>3.0.CO;2-5","article-title":"Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: a meta-analysis of response, toxicity, and survival","volume":"82","author":"Lilenbaum","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jama.292.4.470","article-title":"Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis","volume":"292","author":"Delbaldo","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.lungcan.2008.03.014_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ctrv.2006.07.003","article-title":"Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: meta-analysis of randomized trials","volume":"32","author":"Bria","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2008.03.014_bib38","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1200\/JCO.2006.09.8251","article-title":"Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer","volume":"25","author":"Di","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib39","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A meta-analysis of thoracic radiotherapy for small-cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2008.03.014_bib40","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","article-title":"Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis","volume":"10","author":"Warde","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib41","first-page":"633","article-title":"Critical review of the randomized trials assessing the role of adjuvant thoracic irradiation and chemotherapy in the treatment of limited-stage small cell lung cancer","volume":"15","author":"Luce","year":"1998","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.lungcan.2008.03.014_bib42","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1200\/JCO.2004.01.178","article-title":"Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer","volume":"22","author":"Fried","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib43","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1634\/theoncologist.9-6-665","article-title":"A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer","volume":"9","author":"Huncharek","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2008.03.014_bib44","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2005.02.9793","article-title":"Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer","volume":"24","author":"De","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ctrv.2007.03.002","article-title":"Timing of chest radiotherapy in patients with limited stage small cell lung cancer: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Pijls-Johannesma","year":"2007","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.lungcan.2008.03.014_bib46","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1200\/JCO.2005.05.3181","article-title":"Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis","volume":"24","author":"Spiro","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2008.03.014_bib47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-5002(00)00127-6","article-title":"A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis","volume":"30","author":"Mascaux","year":"2000","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1054\/bjoc.2000.1164","article-title":"Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent","volume":"83","author":"Pujol","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0169-5002(02)00082-X","article-title":"Role of granulocyte and granulocyte\u2013macrophage colony-stimulating factors in the treatment of small-cell lung cancer: a systematic review of the literature with methodological assessment and meta-analysis","volume":"37","author":"Berghmans","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib50","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group","volume":"341","author":"Auperin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2008.03.014_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-1-5","article-title":"Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis","volume":"1","author":"Meert","year":"2001","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib52","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/cncr.21540","article-title":"Does maintenance\/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials","volume":"104","author":"Bozcuk","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-5002(02)00180-0","article-title":"Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis","volume":"38","author":"Berghmans","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2008.03.014_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0197-2456(81)90056-8","article-title":"A method for assessing the quality of a randomized control trial","volume":"2","author":"Chalmers","year":"1981","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.lungcan.2008.03.014_bib55","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/JTO.0b013e31814617a2","article-title":"Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis","volume":"2","author":"Baggstrom","year":"2007","journal-title":"J Thorac Oncol"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208001773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500208001773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T21:46:15Z","timestamp":1557524775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500208001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0169500208001773"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2008.03.014","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}